New Schroders CEO Richard Oldfield has more than halved the size of the asset manager's executive team as he looks to reboot performance after a string of disappointing earnings updates and big ticket ...

AstraZeneca is scheduled to report results for the third quarter on Tuesday. Here is what to know. CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS ...

Not too long ago, pharmaceutical giant Astrazeneca reached a £200bn valuation—one of only a few London-listed FTSE 100 ...

The OBR (Office for Budget Responsibility) anticipates economic output in Britain to expand by 1.8% in 2026 and by 1.5% in ...

The branding agency How&How found that Chester Zoo needed a new brand and website to better reflect its nature-positive ...

When the Houston Rockets needed help with their worst uniforms, they turned to artist and costumer Eiko Ishioka.

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...

At an event held in the House of Lords on 5th November, The Trade Facilitation Commission released their detailed report and ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

AstraZeneca's investment in South African trials has more ... One of the highlights is the LOGOS study where South Africa is a global top recruiter (ex China) contributing 296 patients (13.5% of ...

DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...

Greece’s foreign minister says his country has established a foundation of trust with Turkey ahead of a visit by the Turkish foreign minister to Athens as the two countries try ...